Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy

dc.contributor.authorGuisado Vasco, Pablo
dc.contributor.authorGonzález Cortijo, Lucía
dc.contributor.authorD'Errico, G.
dc.contributor.authorSerrera Álvarez, Alicia
dc.contributor.authorSotres Fernández, Gabriel
dc.contributor.authorGarcía Coca, M.
dc.contributor.authorFernández Sousa, J. M.
dc.contributor.authorLuepke Estefan, X. E.
dc.contributor.authorLópez Martín, J. A.
dc.contributor.authorJimeno, J. M.
dc.date.accessioned2023-03-30T15:36:10Z
dc.date.available2023-03-30T15:36:10Z
dc.date.issued2021
dc.description.filiationUEMspa
dc.description.impact51.769 Q1 JCR 2021spa
dc.description.sponsorshipSin financiaciónspa
dc.identifier.citationGuisado-Vasco, P., González-Cortijo, L., D'Errico, G., Serrera-Álvarez, A., Sotres-Fernández, G., García-Coca, M., Fernández-Sousa, J. M., Luepke-Estefan, X. E., López-Martín, J. A., & Jimeno, J. M. (2021). Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy. Annals of Oncology, 32(10), 1295–1297. https://doi.org/10.1016/j.annonc.2021.07.003spa
dc.identifier.doi10.1016/j.annonc.2021.07.003
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.urihttp://hdl.handle.net/11268/11978
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttps://doi.org/10.1016/j.annonc.2021.07.003spa
dc.rights.accessRightsopen accessspa
dc.subject.otherCOVID-19spa
dc.subject.otherAntineoplásicosspa
dc.subject.otherQuimioterapiaspa
dc.subject.unescoCáncerspa
dc.subject.unescoTratamiento médicospa
dc.subject.unescoMedicamentospa
dc.titlePlitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapyspa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicationf2cb48d1-2d0e-4855-b6c9-fda9346183ee
relation.isAuthorOfPublication.latestForDiscoveryf2cb48d1-2d0e-4855-b6c9-fda9346183ee

Files